{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-095296","form_type":"8-K","ticker":"CGON","cik":"0001991792","company_name":"CG Oncology, Inc.","filed_at":"2025-07-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.769558+00:00","generated_at":"2026-05-18T06:59:47.198697+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CFO Corleen Roche resigns effective Aug 5; Robert Lapetina named interim principal financial officer","bullets":["CFO Corleen Roche resigns effective August 5, 2025.","Robert Lapetina, VP FP&A since May 2024, appointed interim principal financial and accounting officer.","Lapetina previously VP Finance and Controller at Immunome, Inc. and roles at Chubb, Teleflex, Pfizer."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-095296","json":"https://secwatch.observer/filing/0000950170-25-095296.json","markdown":"https://secwatch.observer/filing/0000950170-25-095296.md","text":"https://secwatch.observer/filing/0000950170-25-095296.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1991792/000095017025095296/0000950170-25-095296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1991792/000095017025095296/ck0001991792-20250707.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:59:47.198697+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}